fezolinetant
fezolinetant drug profile: sponsors, targets, indications, therapeutic areas and regulatory status with source links.
MODALITYSmall molecule neurokinin-3 receptor antagonist
TARGETSNK3 receptor
ALIASESVeoza · Veozah · ESN364
Indications
Therapeutic areas
Regulatory status
FDAApproved
EMAApproved
Sponsors and developers
Primary and company sources
Status labels summarize public records and do not replace regulator databases or prescribing information.
Evidence & limits
Source: Open the source record
- Record identifier
- /drugs/fezolinetant/
- Event / action date
- Not separately retained
- Source update date
- Not separately retained
- Platform retrieval / processing date
- Not separately retained
What it supports. The linked authority’s action, within the product, indication, jurisdiction, and procedural stage stated in that record.
Limits. A committee opinion, draft, or announcement does not by itself establish final authorization. The summary and contextual analysis are AI-assisted; a source link does not establish human review.
Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.